ES2436758T3 - Compuestos de aminopirimidina y sus sales, proceso de preparación y su uso farmacéutico - Google Patents

Compuestos de aminopirimidina y sus sales, proceso de preparación y su uso farmacéutico Download PDF

Info

Publication number
ES2436758T3
ES2436758T3 ES05822296.9T ES05822296T ES2436758T3 ES 2436758 T3 ES2436758 T3 ES 2436758T3 ES 05822296 T ES05822296 T ES 05822296T ES 2436758 T3 ES2436758 T3 ES 2436758T3
Authority
ES
Spain
Prior art keywords
amino
compound
methyl
halogen
pyrid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05822296.9T
Other languages
English (en)
Spanish (es)
Inventor
Aifeng Lv
Baohai Yang
Chunyong Hu
Piaoyang Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2436758T3 publication Critical patent/ES2436758T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES05822296.9T 2004-12-31 2005-12-26 Compuestos de aminopirimidina y sus sales, proceso de preparación y su uso farmacéutico Expired - Lifetime ES2436758T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN200410103077 2004-12-31
CN200410103077 2004-12-31
CNA2005101074022A CN1939910A (zh) 2004-12-31 2005-09-30 氨基嘧啶类化合物及其盐和其制备方法与药物用途
CN200510107402 2005-09-30
PCT/CN2005/002308 WO2006069525A1 (en) 2004-12-31 2005-12-26 Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof

Publications (1)

Publication Number Publication Date
ES2436758T3 true ES2436758T3 (es) 2014-01-07

Family

ID=36614492

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05822296.9T Expired - Lifetime ES2436758T3 (es) 2004-12-31 2005-12-26 Compuestos de aminopirimidina y sus sales, proceso de preparación y su uso farmacéutico

Country Status (7)

Country Link
US (1) US8183242B2 (cg-RX-API-DMAC7.html)
EP (1) EP1840122B1 (cg-RX-API-DMAC7.html)
JP (1) JP4698681B2 (cg-RX-API-DMAC7.html)
CN (1) CN1939910A (cg-RX-API-DMAC7.html)
CA (1) CA2602738C (cg-RX-API-DMAC7.html)
ES (1) ES2436758T3 (cg-RX-API-DMAC7.html)
WO (1) WO2006069525A1 (cg-RX-API-DMAC7.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds
US9062023B2 (en) * 2007-06-07 2015-06-23 Intra-Cellular Therapies, Inc. Heterocycle compounds and uses thereof
US8367686B2 (en) 2007-06-07 2013-02-05 Intra-Cellular Therapies, Inc. Heterocycle compounds and uses thereof
WO2011075560A1 (en) * 2009-12-17 2011-06-23 Merck Sharp & Dohme Corp. Aminopyrimidines as syk inhibitors
CN102796079B (zh) * 2011-05-27 2016-06-29 江苏豪森药业集团有限公司 一种甲磺酸氟马替尼的制备方法
CN102816147B (zh) * 2011-06-09 2016-06-08 江苏豪森药业集团有限公司 甲磺酸氟马替尼晶型b及其制备方法和用途
CN102816146A (zh) * 2011-06-10 2012-12-12 江苏豪森医药集团连云港宏创医药有限公司 甲磺酸氟马替尼晶型a及其制备方法和用途
CN103709147A (zh) * 2012-10-09 2014-04-09 江苏豪森医药集团连云港宏创医药有限公司 甲磺酸氟马替尼晶型及其制备方法和用途
CN103360366B (zh) * 2013-07-26 2015-04-01 天津禾盛医药技术开发有限公司 N-(5-硝基-2-甲基吡啶基-3-)-4-(3-吡啶基)-2-嘧啶胺及其中间体的制备方法
CN103396395B (zh) * 2013-07-26 2014-09-03 天津法莫西医药科技有限公司 一种合成n-（5-硝基-2-甲基吡啶基-3-）-4-（3-吡啶基）-2-嘧啶胺及其中间体的方法
CN105884746B (zh) * 2016-05-05 2018-09-21 江苏豪森药业集团有限公司 氟马替尼的合成方法
CN107652269A (zh) * 2016-07-26 2018-02-02 江苏豪森药业集团有限公司 甲磺酸氟马替尼中间体纯化方法
US11066404B2 (en) 2018-10-11 2021-07-20 Incyte Corporation Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
CN109438365B (zh) * 2018-12-06 2022-04-05 华南师范大学 N-(3-((4-三氟甲基)-2-嘧啶基)氨基苯基)-2,6-二氟苯磺酰胺衍生物
US11384083B2 (en) 2019-02-15 2022-07-12 Incyte Corporation Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2 inhibitors
WO2020180959A1 (en) 2019-03-05 2020-09-10 Incyte Corporation Pyrazolyl pyrimidinylamine compounds as cdk2 inhibitors
JP2022523562A (ja) * 2019-03-05 2022-04-25 ホンイー アンド アソシエイツ エルエルシー 神経変性疾患および癌の治療のための化合物
WO2020205560A1 (en) 2019-03-29 2020-10-08 Incyte Corporation Sulfonylamide compounds as cdk2 inhibitors
WO2020223469A1 (en) 2019-05-01 2020-11-05 Incyte Corporation N-(1-(methylsulfonyl)piperidin-4-yl)-4,5-di hydro-1h-imidazo[4,5-h]quinazolin-8-amine derivatives and related compounds as cyclin-dependent kinase 2 (cdk2) inhibitors for treating cancer
WO2020223558A1 (en) 2019-05-01 2020-11-05 Incyte Corporation Tricyclic amine compounds as cdk2 inhibitors
PE20221010A1 (es) 2019-08-14 2022-06-15 Incyte Corp Compuestos de imidazolil pirimidinilamina como inhibidores de cdk2
WO2021072232A1 (en) 2019-10-11 2021-04-15 Incyte Corporation Bicyclic amines as cdk2 inhibitors
CN111072636B (zh) * 2019-12-16 2022-08-23 江苏豪森药业集团有限公司 氟马替尼的合成方法
US11981671B2 (en) 2021-06-21 2024-05-14 Incyte Corporation Bicyclic pyrazolyl amines as CDK2 inhibitors
JP2024540411A (ja) 2021-11-08 2024-10-31 プロジェントス・セラピューティクス・インコーポレイテッド 血小板由来成長因子受容体（ｐｄｇｆｒ）アルファ阻害剤及びその使用
US11976073B2 (en) 2021-12-10 2024-05-07 Incyte Corporation Bicyclic amines as CDK2 inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1043531A (zh) 1988-12-12 1990-07-04 衡阳市动力配件厂 合金铸铁气缸套
TW225528B (cg-RX-API-DMAC7.html) * 1992-04-03 1994-06-21 Ciba Geigy Ag
GB9610044D0 (en) 1996-05-14 1996-07-17 Sandoz Ltd Improvements in or relating to organic compounds
GB9619284D0 (en) * 1996-09-16 1996-10-30 Celltech Therapeutics Ltd Chemical compounds
GB9919778D0 (en) * 1999-08-21 1999-10-27 Zeneca Ltd Chemical compounds
GB0021726D0 (en) * 2000-09-05 2000-10-18 Astrazeneca Ab Chemical compounds
GB0022438D0 (en) * 2000-09-13 2000-11-01 Novartis Ag Organic Compounds
EP1377572A1 (en) * 2001-04-10 2004-01-07 Vertex Pharmaceuticals Incorporated Isoxaxole derivatives as inhibitors of src and other protein kinases
US6884804B2 (en) * 2001-05-16 2005-04-26 Vertex Pharmaceuticals Incorporated Inhibitors of Src and other protein kinases
MXPA03011652A (es) * 2001-06-15 2004-05-31 Vertex Pharma 5-(2-aminopirimidin-4-il) benzioxazoles como inhibidores de proteinas cinasa.
US7288547B2 (en) * 2002-03-11 2007-10-30 Schering Ag CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents
GB0215676D0 (en) * 2002-07-05 2002-08-14 Novartis Ag Organic compounds
GB0222514D0 (en) 2002-09-27 2002-11-06 Novartis Ag Organic compounds
AU2003232650A1 (en) * 2003-05-06 2004-11-26 Il Yang Pharm Co., Ltd. N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
CN1805748B (zh) * 2003-06-13 2010-05-26 诺瓦提斯公司 作为raf激酶抑制剂的2-氨基嘧啶衍生物

Also Published As

Publication number Publication date
CA2602738C (en) 2011-12-20
EP1840122A4 (en) 2011-03-09
JP4698681B2 (ja) 2011-06-08
HK1095146A1 (en) 2007-04-27
JP2008526692A (ja) 2008-07-24
US8183242B2 (en) 2012-05-22
CN1939910A (zh) 2007-04-04
EP1840122A1 (en) 2007-10-03
US20080312251A1 (en) 2008-12-18
EP1840122B1 (en) 2013-08-28
CA2602738A1 (en) 2006-07-06
WO2006069525A1 (en) 2006-07-06

Similar Documents

Publication Publication Date Title
ES2436758T3 (es) Compuestos de aminopirimidina y sus sales, proceso de preparación y su uso farmacéutico
ES2645617T3 (es) Pirazol-1-il benceno sulfonamidas como antagonistas del CCR9
JP5700836B2 (ja) Ｎａｄｐｈオキシダーゼインヒビターとしてのピラゾロピリジン誘導体
JP6843888B2 (ja) リジルオキシダーゼのハロアリルアミンインドールおよびアザインドール誘導体阻害剤およびその使用
ES2655030T3 (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
JP5700837B2 (ja) Ｎａｄｐｈオキシダーゼインヒビターとしてのピラゾロピリジン誘導体
TWI250151B (en) Phthalazine derivatives and pharmaceutical composition comprising same
RU2296124C2 (ru) Производные 2-аминоникотинамида и их применение в качестве ингибиторов vegf-рецептора тирозинкиназы
ES2274111T3 (es) Quinolinas como ligandos del receptor de prostaglandinas.
CN104364235B (zh) 作为ttx‑s阻断剂的酰胺衍生物
ES2363109T3 (es) DERIVADOS DE PIRIDONA COMO INHIBIDORES DE MAPK p38alfa.
ES2535212T3 (es) Carboxamido-4-[(4-piridil)amino]-pirimidinas para el tratamiento de la hepatitis C
CN105283443B (zh) 杂环衍生物及其用途
BRPI0813695B1 (pt) Compostos de heteroaril piridil e fenil benzenossulfonamidas fundidas, composição, método de modular a função de ccr2, usos dos compostos e forma cristalina
KR20090091350A (ko) 단백질 키나제 억제제로 유용한 ５-시아노-４-피롤로[２,３ｂ]피리딘-３-일)-피리디민 유도체
AU2012382875A1 (en) Compound as WNT signaling inhibitor, composition, and use thereof
JP2013519724A (ja) Ｎａｄｐｈオキシダーゼ阻害剤としてのピラゾロピペリジン誘導体
TWI324066B (en) A pharmaceutical composition for inhibiting cell migration induced by an angiogenic factor
WO2012088712A1 (en) Compound as wnt signaling inhibitor, composition, and use thereof
ES2602056T3 (es) Derivado de imidazopiridina de utilidad en el tratamiento de la diabetes
CN1972917B (zh) 氨基嘧啶类化合物及其盐和其制备方法与药物用途
TWI841598B (zh) 用於治療雌激素受體陽性乳癌之組合療法
KR100845770B1 (ko) 피라졸로디아제핀계 화합물 및 그의 제조방법
HK1095146B (en) Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof
CN120208920A (zh) 一种异吲哚啉-吡咯烷类衍生物